Showing results (71-80 of 231) with videos related to
Sort By:
Pageof 24
Cancer Research|October 23, 1997
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancerM Widschwendter, J Berger, G Daxenbichler, et al.British Journal of Cancer|January 1, 1997
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cellsC Marth, M Widschwendter, J Kaern, et al.International Journal of Cancer|May 2, 1997
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell linesM Widschwendter, G Daxenbichler, Z Culig, et al.International Journal of Cancer|September 9, 1992
Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cellsC Marth, T Lang, M V Cronauer, et al.Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]A G Zeimet, F Guadagni, C Marth, et al.Pathology, Research and Practice|August 1, 1992
Relationship between quantity of silver stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell linesD Ofner, A Hittmair, C Marth, et al.International Journal of Cancer|December 15, 1994
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cellsC Marth, A Dreps, C Natoli, et al.International Journal of Cancer|September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancerA G Zeimet, C Natoli, M Herold, et al.International Journal of Cancer|July 1, 1994
Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patientsC Marth, G Weiss, A Koza, et al.Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.Pageof 24